Evaluation of the SSTR2-targeted Radiopharmaceutical 177Lu-DOTATATE and SSTR2-specific 68Ga-DOTATATE PET as Imaging Biomarker in Patients with Intracranial MeningiomaSylvia C. Kurz, Erik P. Sulman, Elçin Zan et al.|Clinical Cancer Research|2023Cited by 55
Osimertinib Dose Escalation Induces Regression of Progressive EGFR T790M–Mutant Leptomeningeal Lung AdenocarcinomaChristine Cordova, Matija Snuderl, Abraham Chachoua et al.|Journal of Thoracic Oncology|2017Cited by 22
Plasma cell-free circulating tumor DNA (ctDNA) detection in longitudinally followed glioblastoma patients using <i>TERT</i> promoter mutation-specific droplet digital PCR assays.Christine Cordova, Rajan Jain, Matija Snuderl et al.|Journal of Clinical Oncology|2019Cited by 12
CTNI-57. RADIONUCLIDE THERAPY WITH 177LU-DOTATATE (LUTATHERA) IN ADULTS WITH ADVANCED INTRACRANIAL MENINGIOMA - INTERIM ANALYSIS RESULTS OF A SINGLE-ARM, OPEN-LABEL, MULTICENTER PHASE II STUDYSylvia C. Kurz, Erik P. Sulman, Elçin Zan et al.|Neuro-Oncology|2022Cited by 2
CTNI-53. SINGLE ARM, OPEN-LABEL, MULTICENTER PHASE II STUDY OF THE RADIONUCLIDE 177LU-DOTATATE (LUTATHERA) IN ADULTS WITH ADVANCED INTRACRANIAL MENINGIOMASylvia C. Kurz, Erik P. Sulman, Elçin Zan et al.|Neuro-Oncology|2020Cited by 1